News
Press Kit-
Roll Call
Deadline Approaches on Tim Scott’s Low-Income Tax Incentive
-
EurekAlert!
New research boosts precision of T cell immunotherapies
-
Nature
The battle to tame autoimmunity
-
Nature
Gut Checkpoint: A rising cancer treatment may get a boost from intestinal bacteria
-
Moguldom
Will.i.am Works To Bring Equality To STEM Education With i.am.angel Foundation
-
Parker ICI
Predicting Childhood Leukemia Relapse Using Machine Learning
-
BioCentury
CHECKING OUT THE MICROBIOME
-
BIOPharma Dive
Cancer and the microbiome: What's old is new again
-
Forbes
Inside The Exclusive Event Disrupting The Future Of Tech
-
Nature
Oncologists tap the microbiome in bid to improve immunotherapy outcomes
-
Parker ICI
How the Parker Institute Uses Modern Data Science to Solve Cancer
-
Cision
James Allison, creator of the first immunotherapy to prove highly effective against cancer
-
Fierce Biotech
Tmunity nabs $100M for next-gen T-cell immunotherapies
-
Philadelphia Business Journal
$100M for Tmunity's cancer gene therapy from China, U.S. investors
-
San Francisco Business Journal
Gilead, Parker Institute grab stakes in Penn immunotherapy spinout's $100 million round
-
Xconomy News
Tmunity Reels in $100M for “Next Generation” Cancer Immunotherapy
-
Forbes
Carl June's Cancer Startup Raises $100 Million From Gilead, Sean Parker
-
ENDPOINTS NEWS
Allied with Penn, Tmunity’s cell therapy pioneers bag $100M mega-round to back a breakthrough quest on CAR-T, CRISPR
-
Biocentury
TMUNITY RAISES $100M SERIES A
-
Futurism
The First American CRISPR Trial in Humans Will Target Cancer